Anti-HIV Drugs

This booklet is a starting point for anyone who wants to know about treatments for HIV. It provides basic information about the drugs that fight HIV – known as antiretroviral drugs – and deals briefly with dosing, side-effects, drug interactions and drug resistance. 

Information contained in this booklet has been reviewed by a panel of medical experts. For full details of side-effects and drug interactions, see the product information leaflets that are produced by drug manufacturers for each drug they produce.

This information was correct at the time of going to press (February 2010). The booklet includes information on drugs which have been licensed in the UK or European Union.  

The booklet has been written to help you decide what questions to ask your doctor about any course of treatment you might be considering. We don’t intend it to replace discussion with your doctor about your treatment.

acknowledgements

This edition is revised by Michael Carter.
Tenth edition, 2010.

NAM is grateful to the funders of this booklet series:

• Department of Health

• NHS London HIV & GUM Commissioning Consortium

Thanks to the following for their assistance:

• Dr Julie Fox
  King's College Hospital, London 
• Dr Mark Nelson
  Chelsea and Westminster Hospital, London 
• All pharmaceutical companies which provided product information
  Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Merck, Sharp and Dohme, Roche Products, Tibotec (a division of Janssen-Cilag) and ViiV Healthcare (joint venture of GlaxoSmithKline and Pfizer).